A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.

NCT00240032 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: glatiramer acetate injection with oral cetirizine hydrochloride
DRUG: glatiramer acetate with placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.